Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Colorectal Neoplasms

Free Subscription Articles published in Eur J Surg Oncol Retrieve available abstracts of 134 articles: HTML format

Single Articles

November 2022
1. TAFFURELLI G, Montroni I, Ghignone F, Zattoni D, et al
   Frailty assessment can predict textbook outcomes in senior adults after minimally invasive colorectal cancer surgery.
   Eur J Surg Oncol. 2022 Nov 8. pii: S0748-7983(22)00734.
   PubMed     Abstract available
   
   
   
2. YAMADA S, Morine Y, Ikemoto T, Saito Y, et al
   Inhibitory effect of non-alcoholic steatohepatitis on colon cancer liver metastasis.
   Eur J Surg Oncol. 2022 Nov 4. pii: S0748-7983(22)00718.
   PubMed     Abstract available
   
   
   October 2022
3. BLIND N, Gunnarsson U, Strigard K, Brannstrom F, et al
   The impact of a patient's social network on emergency surgery for colon cancer.
   Eur J Surg Oncol. 2022 Oct 4. pii: S0748-7983(22)00689.
   PubMed     Abstract available
   
   
   
4. CHEN YH, Su YC, Hsu CW, Hsieh MC, et al
   Mortality of patients with metastatic colorectal cancer who received elective or emergent operation after exposure to bevacizumab: A nationwide database study.
   Eur J Surg Oncol. 2022 Oct 1. pii: S0748-7983(22)00688.
   PubMed     Abstract available
   
   
   
5. CHEN X, Huang Z, Zhang Y
   Letter to the editor: "The impact of synchronous liver resection on the risk of anastomotic leakage following elective colorectal resection. A propensity score match analysis on behalf of the iCral study group".
   Eur J Surg Oncol. 2022;48:2233-2234.
   PubMed    
   
   
   
6. GUERRA F
   Reply to: Letter to the Editor: "The impact of synchronous liver resection on the risk of anastomotic leakage following elective colorectal resection. A propensity score match analysis on behalf of the iCral study group".
   Eur J Surg Oncol. 2022;48:2235-2236.
   PubMed    
   
   
   
7. ZHANG Y, Chen Y, Huang J, Wu X, et al
   Mucinous histology is associated with poor prognosis in locally advanced colorectal adenocarcinoma treated with postoperative first-line adjuvant chemotherapy: A systematic review and meta-analysis.
   Eur J Surg Oncol. 2022;48:2075-2081.
   PubMed     Abstract available
   
   
   
8. FLOOD MP, Jain A, Mitchell C, Hewitt C, et al
   The impact of molecular and mismatch repair status on the survival outcomes of surgically treated patients with colorectal peritoneal metastases.
   Eur J Surg Oncol. 2022;48:2218-2225.
   PubMed     Abstract available
   
   
   
9. FRUHLING P, Urdzik J, Isaksson B
   Chemotherapy in patients with a solitary colorectal liver metastasis - A nationwide propensity score matched study.
   Eur J Surg Oncol. 2022;48:2188-2194.
   PubMed     Abstract available
   
   
   September 2022
10. DOLIN TG, Christensen IJ, Lund CM, Bojesen SE, et al
    Preoperative plasma vitamin D in patients with localized colorectal cancer: Age-dependent association with inflammation, postoperative complications, and survival.
    Eur J Surg Oncol. 2022 Sep 11. pii: S0748-7983(22)00651.
    PubMed     Abstract available
    
    
    August 2022
11. VAN LEEUWEN B
    Editorial in response to "Peritoneal metastases in elderly patients with colorectal cancer".
    Eur J Surg Oncol. 2022 Aug 23. pii: S0748-7983(22)00622.
    PubMed    
    
    
    
12. ZOU M, Yang ZQ, Gao F
    Letter to the editor "Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death".
    Eur J Surg Oncol. 2022 Aug 19. pii: S0748-7983(22)00599.
    PubMed    
    
    
    
13. ROMANO G, Di Buono G, Galia M, Agnello F, et al
    Role of preoperative CT angiography with multimodality imaging reconstruction to perform laparoscopic Complete Mesocolic Excision (CME) and Central Vascular Ligation (CVL) in right-sided colon cancer: Is it really useful? A prospective clinical study.
    Eur J Surg Oncol. 2022 Aug 17. pii: S0748-7983(22)00596.
    PubMed     Abstract available
    
    
    
14. ZAMARAY B, van Velzen RA, Snaebjornsson P, Consten ECJ, et al
    Outcomes of patients with perforated colon cancer: A systematic review.
    Eur J Surg Oncol. 2022 Aug 15. pii: S0748-7983(22)00597.
    PubMed     Abstract available
    
    
    
15. HASSAN S, Malcomson L, Soh YJ, Wilson MS, et al
    Patterns and Timing of Recurrence following CRS and HIPEC in Colorectal Cancer Peritoneal Metastasis.
    Eur J Surg Oncol. 2022 Aug 4. pii: S0748-7983(22)00561.
    PubMed     Abstract available
    
    
    
16. KORNER H, Guren MG, Larsen IK, Haugen DF, et al
    Characteristics and fate of patients with rectal cancer not entering a curative-intent treatment pathway: A complete nationwide registry cohort of 3,304 patients.
    Eur J Surg Oncol. 2022;48:1831-1839.
    PubMed     Abstract available
    
    
    July 2022
17. KROON HM, Hoogervorst LA, Hanna-Rivero N, Traeger L, et al
    Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer.
    Eur J Surg Oncol. 2022;48:1475-1482.
    PubMed     Abstract available
    
    
    
18. STROMBERG C, Martinez de la Maza L, Fernandez Moro C, Gerling M, et al
    Prognostic impact of inter-metastatic heterogeneity of viable tumour cells in colorectal liver metastases.
    Eur J Surg Oncol. 2022;48:1656-1663.
    PubMed     Abstract available
    
    
    
19. SUZUKI C, Halperin SK, Nilsson PJ, Martling A, et al
    Initial magnetic resonance imaging tumour regression grade (mrTRG) as response evaluation after neoadjuvant treatment predicts sustained complete response in patients with rectal cancer.
    Eur J Surg Oncol. 2022;48:1643-1649.
    PubMed     Abstract available
    
    
    
20. FUKUI Y, Hida K, Hoshino N, Song SH, et al
    Oncologic benefit of adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and curative surgery with selective lateral pelvic lymph node dissection: An international retrospective cohort study.
    Eur J Surg Oncol. 2022;48:1631-1637.
    PubMed     Abstract available
    
    
    June 2022
21. BHIMANI N, Wong GY, Molloy C, Dieng M, et al
    Cost of colorectal cancer by treatment type from different health economic perspectives: A systematic review.
    Eur J Surg Oncol. 2022 Jun 23. pii: S0748-7983(22)00528.
    PubMed     Abstract available
    
    
    
22. ZWANENBURG ES, Gehrels AM, Bastiaenen VP, Aalbers AGJ, et al
    Metachronous peritoneal metastases in patients with pT4b colon cancer: An international multicenter analysis of intraperitoneal versus retroperitoneal tumor invasion.
    Eur J Surg Oncol. 2022 Jun 11. pii: S0748-7983(22)00478.
    PubMed     Abstract available
    
    
    
23. BIRGIN E, Doyon F, Burkert J, Teoule P, et al
    Prognostic value of disease-free interval in colorectal cancer: Is it time?
    Eur J Surg Oncol. 2022 Jun 3. pii: S0748-7983(22)00485.
    PubMed     Abstract available
    
    
    
24. MOHAMED A, Nicolais L, Fitzgerald TL
    Predicting loss of independence after high-risk gastrointestinal abdominal surgery: Frailty vs. NSQIP risk calculator.
    Eur J Surg Oncol. 2022;48:1433-1438.
    PubMed     Abstract available
    
    
    
25. VAN GESTEL T, Groen LCB, Puik JR, van Rooijen SJ, et al
    Fit4Surgery for cancer patients during covid-19 lockdown - A systematic review and meta-analysis.
    Eur J Surg Oncol. 2022;48:1189-1197.
    PubMed     Abstract available
    
    
    
26. VAN DE GEEST TW, van Amerongen MJ, Nierop PMH, Hoppener DJ, et al
    Propensity score matching demonstrates similar results for radiofrequency ablation compared to surgical resection in colorectal liver metastases.
    Eur J Surg Oncol. 2022;48:1368-1374.
    PubMed     Abstract available
    
    
    
27. DI MARTINO M, Dorcaratto D, Primavesi F, Syn N, et al
    Liver resection in elderly patients with extensive CRLM: Are we offering an adequate treatment? A propensity score matched analysis.
    Eur J Surg Oncol. 2022;48:1331-1338.
    PubMed     Abstract available
    
    
    
28. KETELAERS SHJ, Orsini RG, Nieuwenhuijzen GAP, Rutten HJT, et al
    Outcomes on diverting ostomy formation and reversal after low anterior resection in the older more advanced rectal cancer patient.
    Eur J Surg Oncol. 2022;48:1414-1420.
    PubMed     Abstract available
    
    
    May 2022
29. STURESSON C, Engstrand J, Stromberg C
    Reply to: The cohort data in the full pulmonary Metastasectomy in colorectal cancer study: Comment on Engstrand et al.
    Eur J Surg Oncol. 2022 May 27. pii: S0748-7983(22)00471.
    PubMed    
    
    
    
30. FEENSTRA TM, Verberne CJ, Kok NF, Aalbers AGJ, et al
    Anastomotic leakage after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal cancer.
    Eur J Surg Oncol. 2022 May 22. pii: S0748-7983(22)00463.
    PubMed     Abstract available
    
    
    
31. SCHUURMAN MS, Elferink MAG, Verhoef C, de Hingh IHJT, et al
    Peritoneal metastases in elderly patients with colorectal cancer.
    Eur J Surg Oncol. 2022 May 18. pii: S0748-7983(22)00438.
    PubMed     Abstract available
    
    
    
32. AGRAWAL A, Kazi M, Gori J, Dev I, et al
    Prospective study to assess the role of FDG PET/CT in detecting systemic metastatic spread in rectal cancers with lateral pelvic lymph nodes.
    Eur J Surg Oncol. 2022;48:1093-1099.
    PubMed     Abstract available
    
    
    
33. ABD EL AZIZ MA, McKenna NP, Jakub JW, Hallemeier CL, et al
    Rectal cancer with synchronous inguinal lymph node metastasis without distant metastasis. A call for further oncological evaluation.
    Eur J Surg Oncol. 2022;48:1100-1103.
    PubMed     Abstract available
    
    
    
34. SUKUMAR V, Kazi M, Gori J, Ankathi SK, et al
    Learning curve analysis for lateral pelvic lymph node dissection in rectal cancers - Outcomes improve with experience.
    Eur J Surg Oncol. 2022;48:1110-1116.
    PubMed     Abstract available
    
    
    
35. GIESEN LJX, Olthof PB, Elferink MAG, van Westreenen HL, et al
    Changes in rectal cancer treatment after the introduction of a national screening program; Increasing use of less invasive strategies within a national cohort.
    Eur J Surg Oncol. 2022;48:1117-1122.
    PubMed     Abstract available
    
    
    
36. VERSEVELD M, Verver D, Noordman BJ, Pouwels S, et al
    Treatment of clinical T1 rectal cancer in the Netherlands; a population-based overview of clinical practice.
    Eur J Surg Oncol. 2022;48:1153-1160.
    PubMed     Abstract available
    
    
    
37. LIM WH, Tan DJH, Ng CH, Syn N, et al
    Laparoscopic versus open resection for rectal cancer: An individual patient data meta analysis of randomized controlled trials.
    Eur J Surg Oncol. 2022;48:1133-1143.
    PubMed     Abstract available
    
    
    
38. ASSI H, Persson A, Palmquist I, Oberg M, et al
    Short-term outcomes following beyond total mesorectal excision and reconstruction using myocutaneous flaps: A retrospective cohort study.
    Eur J Surg Oncol. 2022;48:1161-1166.
    PubMed     Abstract available
    
    
    April 2022
39. STRUYS M, Ceelen W
    Incidence of lymph node recurrence after primary surgery for non-metastatic colon cancer: A systematic review.
    Eur J Surg Oncol. 2022 Apr 27. pii: S0748-7983(22)00414.
    PubMed     Abstract available
    
    
    
40. CUIJPERS ACM, Linskens FG, Bongers BC, Stassen LPS, et al
    Quality and clinical generalizability of feasibility outcomes in exercise prehabilitation before colorectal cancer surgery - A systematic review.
    Eur J Surg Oncol. 2022 Apr 23. pii: S0748-7983(22)00406.
    PubMed     Abstract available
    
    
    
41. TREASURE T, Williams NR, Macbeth F
    The cohort data in the full pulmonary metastasectomy in colorectal cancer study: Comment on Engstrand et al.
    Eur J Surg Oncol. 2022 Apr 23. pii: S0748-7983(22)00408.
    PubMed    
    
    
    
42. PEDRAZZANI C, Kim HJ, Park EJ, Turri G, et al
    Does laparoscopy increase the risk of peritoneal recurrence after resection for pT4 colon cancer? Results of a propensity score-matched analysis from an international cohort.
    Eur J Surg Oncol. 2022 Apr 22. pii: S0748-7983(22)00409.
    PubMed     Abstract available
    
    
    
43. CHAN AK, Ignatowicz AM, Mason JM, Siriwardena AK, et al
    Colorectal cancer and synchronous liver metastases: An individual case-based qualitative study (CoSMIC-Q).
    Eur J Surg Oncol. 2022 Apr 14. pii: S0748-7983(22)00385.
    PubMed     Abstract available
    
    
    
44. BOOME IT, Somers AMJ, Graupner C, Kimman ML, et al
    Development and content validation of the Assessment of Burden of ColoRectal Cancer (ABCRC)-tool.
    Eur J Surg Oncol. 2022 Apr 7. pii: S0748-7983(22)00379.
    PubMed     Abstract available
    
    
    
45. NORS J, Iversen LH, Nielsen K, Sorensen MM, et al
    Peritoneal metastases found in routinely resected specimens after cytoreductive surgery and heated intraperitoneal chemotherapy.
    Eur J Surg Oncol. 2022;48:795-802.
    PubMed     Abstract available
    
    
    
46. O'CONNELL E, McDevitt J, Hill ADK, McNamara DA, et al
    Centralisation of rectal cancer care has improved patient survival in the republic of Ireland.
    Eur J Surg Oncol. 2022;48:890-895.
    PubMed     Abstract available
    
    
    
47. HORIE K, Matsuda T, Yamashita K, Hasegawa H, et al
    Sarcopenia assessed by skeletal muscle mass volume is a prognostic factor for oncological outcomes of rectal cancer patients undergoing neoadjuvant chemoradiotherapy followed by surgery.
    Eur J Surg Oncol. 2022;48:850-856.
    PubMed     Abstract available
    
    
    
48. CHEN Q, Chen J, Huang Z, Zhao H, et al
    Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors.
    Eur J Surg Oncol. 2022;48:864-872.
    PubMed     Abstract available
    
    
    
49. FOPPA C, Tamburello S, Maroli A, Carvello M, et al
    Early age of onset is an independent predictor for worse disease-free survival in sporadic rectal cancer patients. A comparative analysis of 980 consecutive patients.
    Eur J Surg Oncol. 2022;48:857-863.
    PubMed     Abstract available
    
    
    
50. KRUL MF, Gerritsen SL, Vissers FL, Klompenhouwer EG, et al
    Radiofrequency versus microwave ablation for intraoperative treatment of colorectal liver metastases.
    Eur J Surg Oncol. 2022;48:834-840.
    PubMed     Abstract available
    
    
    March 2022
51. PRING ET, Malietzis G, Gould LE, Lung P, et al
    Tumour grade and stage are associated with specific body composition phenotypes with visceral obesity predisposing the host to a less aggressive tumour in colorectal cancer.
    Eur J Surg Oncol. 2022 Mar 19. pii: S0748-7983(22)00134.
    PubMed     Abstract available
    
    
    
52. ENGSTRAND J, Sterner J, Hasselgren K, Stromberg C, et al
    Treatment intention and outcome in patients with simultaneously diagnosed liver and lung metastases from colorectal cancer.
    Eur J Surg Oncol. 2022 Mar 11. pii: S0748-7983(22)00128.
    PubMed     Abstract available
    
    
    
53. MADONIA D, Graf W, Ghanipour L
    The incidence and prognostic importance of ovarian involvement in patients with peritoneal metastasis undergoing CRS-HIPEC.
    Eur J Surg Oncol. 2022;48:666-671.
    PubMed     Abstract available
    
    
    
54. BAJRIC T, Kornprat P, Faschinger F, Werkgartner G, et al
    Sarcopenia and primary tumor location influence patients outcome after liver resection for colorectal liver metastases.
    Eur J Surg Oncol. 2022;48:615-620.
    PubMed     Abstract available
    
    
    February 2022
55. MC ENTEE PD, Shokuhi P, Rogers AC, Mehigan BJ, et al
    Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death.
    Eur J Surg Oncol. 2022 Feb 19. pii: S0748-7983(22)00090.
    PubMed     Abstract available
    
    
    
56. SARJANOJA E, Klintrup K, Ohtonen P, Kauppila JH, et al
    Annual hospital volume and colorectal cancer survival in a population-based nationwide cohort study in Finland.
    Eur J Surg Oncol. 2022 Feb 18. pii: S0748-7983(22)00111.
    PubMed     Abstract available
    
    
    
57. SUGARBAKER PH, Chang D
    Peritoneal metastases from colorectal cancer in the absence of lymph node metastases show a high survival rate despite unfavorable prognostic indicators.
    Eur J Surg Oncol. 2022 Feb 3. pii: S0748-7983(22)00074.
    PubMed     Abstract available
    
    
    
58. UEDA K, Yamada T, Ohta R, Matsuda A, et al
    BRAF V600E mutations in right-side colon cancer: Heterogeneity detected by liquid biopsy.
    Eur J Surg Oncol. 2022 Feb 2. pii: S0748-7983(22)00042.
    PubMed     Abstract available
    
    
    
59. ELFRINK AKE, Kok NFM, Swijnenburg RJ, den Dulk M, et al
    Nationwide oncological networks for resection of colorectal liver metastases in the Netherlands: Differences and postoperative outcomes.
    Eur J Surg Oncol. 2022;48:435-448.
    PubMed     Abstract available
    
    
    
60. AMROUN K, Scholer V, Djerada Z, Renard Y, et al
    Inflammatory biomarkers to predict postoperative infectious complications after cytoreductive surgery and HIPEC for peritoneal carcinomatosis.
    Eur J Surg Oncol. 2022;48:455-461.
    PubMed     Abstract available
    
    
    
61. VAN 'T SANT I, Nerad E, Rijsemus CJV, Engbersen MP, et al
    Seeing the whole picture: Added value of MRI for extraperitoneal findings in CRS-HIPEC candidates.
    Eur J Surg Oncol. 2022;48:462-469.
    PubMed     Abstract available
    
    
    January 2022
62. CHO HJ, Lee IK, Lee YS, Yun SS, et al
    Application of venous thromboembolism prophylaxis program in patients with colorectal cancer using the enhanced recovery after surgery protocol.
    Eur J Surg Oncol. 2022 Jan 31. pii: S0748-7983(22)00048.
    PubMed     Abstract available
    
    
    
63. SUGARBAKER PH, Chang D
    Anatomic sites of disease in colorectal cancer patients recorded at the time of cytoreductive surgery for peritoneal metastases.
    Eur J Surg Oncol. 2022 Jan 13. pii: S0748-7983(22)00011.
    PubMed     Abstract available
    
    
    
64. VAN DORP M, Bousema JE, Torensma B, Dickhoff C, et al
    Pulmonary metastasectomy with lymphadenectomy for colorectal pulmonary metastases: A systematic review.
    Eur J Surg Oncol. 2022;48:253-260.
    PubMed     Abstract available
    
    
    
65. NG L, Li X, Wan TM, Iyer D, et al
    Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells.
    Eur J Surg Oncol. 2022;48:245-252.
    PubMed     Abstract available
    
    
    
66. BOGVERADZE N, Lambregts DMJ, El Khababi N, Dresen RC, et al
    The sigmoid take-off as a landmark to distinguish rectal from sigmoid tumours on MRI: Reproducibility, pitfalls and potential impact on treatment stratification.
    Eur J Surg Oncol. 2022;48:237-244.
    PubMed     Abstract available
    
    
    
67. MORAIS M, Pinto DM, Machado JC, Carneiro S, et al
    ctDNA on liquid biopsy for predicting response and prognosis in locally advanced rectal cancer: A systematic review.
    Eur J Surg Oncol. 2022;48:218-227.
    PubMed     Abstract available
    
    
    
68. ASSAF D, Mor E, Laks S, Zohar N, et al
    The pattern of peritoneal colorectal metastasis predicts survival after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.
    Eur J Surg Oncol. 2022;48:197-203.
    PubMed     Abstract available
    
    
    
69. MA SM, Dong J, Liang L, Liu XT, et al
    The prognostic and clinicopathological roles of microsatellite instability, PD-L1 expression and tumor-infiltrating leukocytes in familial adenomatous polyposis.
    Eur J Surg Oncol. 2022;48:211-217.
    PubMed     Abstract available
    
    
    
70. VERWAAL VJ, Funder JA, Sorensen MM, Iversen LH, et al
    The impact of postoperative complications following cytoreductive surgery combined with oxaliplatin based heated intraperitoneal chemotherapy.
    Eur J Surg Oncol. 2022;48:183-187.
    PubMed     Abstract available
    
    
    
71. VILLAMONTE M, Burdio F, Pueyo E, Andaluz A, et al
    The impact of additional margin coagulation with radiofrequency in liver resections with subcentimetric margin: can we improve the oncological results? A propensity score matching study.
    Eur J Surg Oncol. 2022;48:82-88.
    PubMed     Abstract available
    
    
    December 2021
72. DUMONT F, Guenole S, Loaec C, Bourgin C, et al
    Survival after cytoreductive surgery for peritoneal metastases in colorectal cancer patients: Does a history of resected liver metastases worsen the prognosis?
    Eur J Surg Oncol. 2021 Dec 22. pii: S0748-7983(21)00995.
    PubMed     Abstract available
    
    
    
73. MEYER Y, Olthof PB, Grunhagen DJ, de Hingh I, et al
    Treatment of metachronous colorectal cancer metastases in the Netherlands: A population-based study.
    Eur J Surg Oncol. 2021 Dec 4. pii: S0748-7983(21)00951.
    PubMed     Abstract available
    
    
    
74. PIOZZI GN, Rusli SM, Baek SJ, Kwak JM, et al
    Infrapyloric and gastroepiploic node dissection for hepatic flexure and transverse colon cancer: A systematic review.
    Eur J Surg Oncol. 2021 Dec 4. pii: S0748-7983(21)00952.
    PubMed     Abstract available
    
    
    
75. BOSMA NA, Keehn AR, Lee-Ying R, Karim S, et al
    Efficacy of perioperative chemotherapy in resected colorectal liver metastasis: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2021;47:3113-3122.
    PubMed     Abstract available
    
    
    
76. SPINELLI A, Foppa C, Carvello M, Sacchi M, et al
    Transanal Transection and Single-Stapled Anastomosis (TTSS): A comparison of anastomotic leak rates with the double-stapled technique and with transanal total mesorectal excision (TaTME) for rectal cancer.
    Eur J Surg Oncol. 2021;47:3123-3129.
    PubMed     Abstract available
    
    
    
77. WANG Z, Liu Z, Wen Z, Li R, et al
    Evaluation of radical surgical treatment in the management of 58 locally advanced rectal neuroendocrine neoplasms, one multicenter retrospective study.
    Eur J Surg Oncol. 2021;47:3166-3174.
    PubMed     Abstract available
    
    
    
78. AKIYOSHI T, Yamaguchi T, Hiratsuka M, Mukai T, et al
    Oncologic impact of lateral lymph node metastasis at the distal lateral compartment in locally advanced low rectal cancer after neoadjuvant (chemo)radiotherapy.
    Eur J Surg Oncol. 2021;47:3157-3165.
    PubMed     Abstract available
    
    
    
79. ZHENG Z, Wang X, Liu Z, Lu X, et al
    Individualized conditional survival nomograms for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and radical surgery.
    Eur J Surg Oncol. 2021;47:3175-3181.
    PubMed     Abstract available
    
    
    November 2021
80. BENAVIDES M, Gomez-Espana A, Garcia-Alfonso P, Gonzalez CG, et al
    Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
    Eur J Surg Oncol. 2021 Nov 25. pii: S0748-7983(21)00931.
    PubMed     Abstract available
    
    
    
81. WARPS AK, Tollenaar RAEM, Tanis PJ, Dekker JWT, et al
    Postoperative complications after colorectal cancer surgery and the association with long-term survival.
    Eur J Surg Oncol. 2021 Nov 11. pii: S0748-7983(21)00785.
    PubMed     Abstract available
    
    
    
82. DE NES LCF, van der Heijden JAG, Verstegen MG, Drager L, et al
    Predictors of undergoing multivisceral resection, margin status and survival in Dutch patients with locally advanced colorectal cancer.
    Eur J Surg Oncol. 2021 Nov 6. pii: S0748-7983(21)00789.
    PubMed     Abstract available
    
    
    
83. WARPS AK, Detering R, Tollenaar RAEM, Tanis PJ, et al
    Textbook outcome after rectal cancer surgery as a composite measure for quality of care: A population-based study.
    Eur J Surg Oncol. 2021;47:2821-2829.
    PubMed     Abstract available
    
    
    
84. GUERRA F, Petrelli F, Greco PA, Sisti V, et al
    The impact of synchronous liver resection on the risk of anastomotic leakage following elective colorectal resection. A propensity score match analysis on behalf of the iCral study group.
    Eur J Surg Oncol. 2021;47:2873-2879.
    PubMed     Abstract available
    
    
    
85. LJUNGGREN M, Nordenvall C, Palmer G
    Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases.
    Eur J Surg Oncol. 2021;47:2865-2872.
    PubMed     Abstract available
    
    
    
86. GAU L, Ribeiro M, Pereira B, Poirot K, et al
    Impact of BRAF mutations on clinical outcomes following liver surgery for colorectal liver metastases: An updated meta-analysis.
    Eur J Surg Oncol. 2021;47:2722-2733.
    PubMed     Abstract available
    
    
    
87. BAE HW, Kim HS, Yang SY, Kim HS, et al
    Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases.
    Eur J Surg Oncol. 2021;47:2814-2820.
    PubMed     Abstract available
    
    
    
88. VAN DE VLASAKKER VCJ, Lurvink RJ, Cashin PH, Ceelen W, et al
    The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI).
    Eur J Surg Oncol. 2021;47:2888-2892.
    PubMed     Abstract available
    
    
    October 2021
89. DI GIORGIO A, Rotolo S, Cintoni M, Rinninella E, et al
    The prognostic value of skeletal muscle index on clinical and survival outcomes after cytoreduction and HIPEC for peritoneal metastases from colorectal cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2021 Oct 16. pii: S0748-7983(21)00763.
    PubMed     Abstract available
    
    
    
90. HODGES N, Mackenzie H, D'Souza N, Brown G, et al
    Survival outcomes for right-versus left-sided colon cancer and rectal cancer in England: A propensity-score matched population-based cohort study.
    Eur J Surg Oncol. 2021 Oct 16. pii: S0748-7983(21)00760.
    PubMed     Abstract available
    
    
    
91. GALEMA HA, Meijer RPJ, Lauwerends LJ, Verhoef C, et al
    Fluorescence-guided surgery in colorectal cancer; A review on clinical results and future perspectives.
    Eur J Surg Oncol. 2021 Oct 9. pii: S0748-7983(21)00755.
    PubMed     Abstract available
    
    
    
92. KATAOKA K, Yamada T, Taniguchi H, Ikeda M, et al
    A ctDNA-driven multidisciplinary treatment strategy for resectable colorectal cancer -what surgical oncologists should know.
    Eur J Surg Oncol. 2021 Oct 7. pii: S0748-7983(21)00752.
    PubMed    
    
    
    
93. FIORICA F, Napoli G, Berretta M, Soliani G, et al
    Letter to editor: A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours.
    Eur J Surg Oncol. 2021;47:2700-2701.
    PubMed    
    
    
    
94. YUKSEL BC
    Comment on 'Local recurrence in sigmoid cancer is a hidden problem, could CT prognostic factors be of value in their prevention? A multi-centre study of 414 patients'.
    Eur J Surg Oncol. 2021;47:2696.
    PubMed    
    
    
    
95. CLANCY C, Martin ST
    Reply to: Commentary to "A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours".
    Eur J Surg Oncol. 2021;47:2702-2703.
    PubMed    
    
    
    
96. GIGLIO MC, Garofalo E, Montalti R, Vanlander A, et al
    The learning curve of laparoscopic ablation of liver tumors: A technically demanding procedure requiring dedicated training.
    Eur J Surg Oncol. 2021;47:2579-2585.
    PubMed     Abstract available
    
    
    September 2021
97. KROON HM, Kusters M, Chang GJ, Sammour T, et al
    Reply to: Lateral lymph node dissection in low rectal cancers: Call for standardized reporting of results to unify the global practice.
    Eur J Surg Oncol. 2021;47:2477-2478.
    PubMed    
    
    
    
98. PATEL S, Kazi M, Saklani A
    Lateral lymph node dissection in low rectal cancers: Call for standardized reporting of results to unify the global practice.
    Eur J Surg Oncol. 2021;47:2475-2476.
    PubMed    
    
    
    
99. VOOGT ELK, Schaap DP, van den Berg K, Nieuwenhuijzen GAP, et al
    Reply to: Use of induction chemotherapy in locally advanced rectal cancers to increase the response rates: Is it actually helping?
    Eur J Surg Oncol. 2021;47:2473-2474.
    PubMed    
    
    
    
100. PATEL S, Prem A, Raghavan S
     Use of induction chemotherapy in locally advanced rectal cancers to increase the response rates: Is it actually helping?
     Eur J Surg Oncol. 2021;47:2472.
     PubMed    
     
     
     
101. DAY N
     Reply to: CT defined prognostic factors for local recurrence after sigmoid resection - How relevant are they?
     Eur J Surg Oncol. 2021;47:2467.
     PubMed    
     
     
     
102. KROON HM, Malakorn S, Dudi-Venkata NN, Bedrikovetski S, et al
     Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
     Eur J Surg Oncol. 2021;47:2441-2449.
     PubMed     Abstract available
     
     
     
103. MARIATHASAN AB, Boye K, Dueland S, Flatmark K, et al
     Metastases in locally advanced rectal cancer undergoing curatively intended treatment.
     Eur J Surg Oncol. 2021;47:2377-2383.
     PubMed     Abstract available
     
     
     
104. VOOGT ELK, Schaap DP, van den Berg K, Nieuwenhuijzen GAP, et al
     Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control study.
     Eur J Surg Oncol. 2021;47:2429-2435.
     PubMed     Abstract available
     
     
     
105. FAHIM M, Dijksman LM, Derksen WJM, Bloemen JG, et al
     Prospective multicentre study of a new bowel obstruction treatment in colorectal surgery: Reduced morbidity and mortality.
     Eur J Surg Oncol. 2021;47:2414-2420.
     PubMed     Abstract available
     
     
     
106. MORARASU S, O'Brien L, Clancy C, Dietrich D, et al
     A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours.
     Eur J Surg Oncol. 2021;47:2421-2428.
     PubMed     Abstract available
     
     
     
107. KAZI M, Saklani A
     CT defined prognostic factors for local recurrence after sigmoid resection - How relevant are they?
     Eur J Surg Oncol. 2021;47:2465-2466.
     PubMed    
     
     
     
108. GIESEN LJX, Olthof PB, Elferink MAG, Verhoef C, et al
     Surgery for rectal cancer: Differences in resection rates among hospitals in the Netherlands.
     Eur J Surg Oncol. 2021;47:2384-2389.
     PubMed     Abstract available
     
     
     
109. CALINI G, Abd El Aziz MA, Abdalla S, Saeed HA, et al
     Patient colon and rectal operative outcomes when treated with immune checkpoint inhibitors.
     Eur J Surg Oncol. 2021;47:2436-2440.
     PubMed     Abstract available
     
     
     August 2021
110. DASTER S, Shin JS, Loizides S, Steffens D, et al
     Pathology reporting of pelvic exenteration specimens for locally recurrent rectal cancer.
     Eur J Surg Oncol. 2021;47:2100-2107.
     PubMed     Abstract available
     
     
     
111. DAY N, D'Souza N, Shaw A, Lord A, et al
     Local recurrence in sigmoid cancer is a hidden problem, could CT prognostic factors be of value in their prevention? A multi-centre study of 414 patients.
     Eur J Surg Oncol. 2021;47:2093-2099.
     PubMed     Abstract available
     
     
     
112. LI K, He X, Tong S, Zheng Y, et al
     Risk factors for sexual dysfunction after rectal cancer surgery in 948 consecutive patients: A prospective cohort study.
     Eur J Surg Oncol. 2021;47:2087-2092.
     PubMed     Abstract available
     
     
     
113. WILSON K, Flood M, Narasimhan V, Pham T, et al
     Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review.
     Eur J Surg Oncol. 2021;47:1862-1874.
     PubMed     Abstract available
     
     
     
114. KLOSE J, Schmitt A, Pernthaler J, Warschkow R, et al
     Still proliferating CD44(+)/Ki67(+) tumor cells after neoadjuvant radiochemotherapy identify rectal cancer patients with poor survival.
     Eur J Surg Oncol. 2021;47:2078-2086.
     PubMed     Abstract available
     
     
     
115. PIOZZI GN, Park H, Lee TH, Kim JS, et al
     Risk factors for local recurrence and long term survival after minimally invasive intersphincteric resection for very low rectal cancer: Multivariate analysis in 161 patients.
     Eur J Surg Oncol. 2021;47:2069-2077.
     PubMed     Abstract available
     
     
     
116. LANCELLOTTI F, Solinas L, Sagnotta A, Mancini S, et al
     Short course radiotherapy and delayed surgery for locally advanced rectal cancer in frail patients: is it a valid option?
     Eur J Surg Oncol. 2021;47:2046-2052.
     PubMed     Abstract available
     
     
     
117. VILLARD C, Habib M, Nordenvall C, Nilsson PJ, et al
     Conversion therapy in patients with colorectal liver metastases.
     Eur J Surg Oncol. 2021;47:2038-2045.
     PubMed     Abstract available
     
     
     July 2021
118. KIM JC, Kim CW, Lee JL, Yoon YS, et al
     Complete intersphincteric longitudinal muscle excision May Be key to reducing local recurrence during intersphincteric resection.
     Eur J Surg Oncol. 2021;47:1629-1636.
     PubMed     Abstract available
     
     
     
119. DU R, Zhou J, Tong G, Chang Y, et al
     Postoperative morbidity and mortality after anterior resection with preventive diverting loop ileostomy versus loop colostomy for rectal cancer: A updated systematic review and meta-analysis.
     Eur J Surg Oncol. 2021;47:1514-1525.
     PubMed     Abstract available
     
     
     
120. DENOST Q, Assenat V, Vendrely V, Celerier B, et al
     Oncological strategy following R1 sphincter-saving resection in low rectal cancer after chemoradiotherapy.
     Eur J Surg Oncol. 2021;47:1683-1690.
     PubMed     Abstract available
     
     
     
121. WANG T, Zhao Y, Wang M, Zhang P, et al
     Radical resection versus local excision for low rectal gastrointestinal stromal tumor: A multicenter propensity score-matched analysis.
     Eur J Surg Oncol. 2021;47:1668-1674.
     PubMed     Abstract available
     
     
     
122. VAN REES JM, Hoppener DJ, Hagemans JAW, Rothbarth J, et al
     The clinical relevance of indeterminate lung nodules in patients with locally recurrent rectal cancer.
     Eur J Surg Oncol. 2021;47:1616-1622.
     PubMed     Abstract available
     
     
     June 2021
123. KAECH M, Deutschmann E, Moffa G, Haak F, et al
     Influence of the introduction of caseload requirements on indication for visceral cancer surgery in Switzerland.
     Eur J Surg Oncol. 2021;47:1324-1331.
     PubMed     Abstract available
     
     
     
124. CLIFFORD RE, Gerrard AD, Fok M, Vimalachandran D, et al
     Metformin as a radiosensitiser for pelvic malignancy: A systematic review of the literature.
     Eur J Surg Oncol. 2021;47:1252-1257.
     PubMed     Abstract available
     
     
     
125. ARJONA-SANCHEZ A, Aziz O, Passot G, Salti G, et al
     Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry.
     Eur J Surg Oncol. 2021;47:1420-1426.
     PubMed     Abstract available
     
     
     May 2021
126. YE J, Tian Y, Li F, van Oostendorp S, et al
     Comparison of transanal total mesorectal excision (TaTME) versus laparoscopic TME for rectal cancer: A case matched study.
     Eur J Surg Oncol. 2021;47:1019-1025.
     PubMed     Abstract available
     
     
     
127. MEILLAT H, Braticevic C, Zemmour C, Brun C, et al
     Real-world implementation of a geriatric-specific ERAS protocol in patients undergoing colonic cancer surgery.
     Eur J Surg Oncol. 2021;47:1012-1018.
     PubMed     Abstract available
     
     
     
128. OGURA A, Uehara K, Aiba T, Sando M, et al
     Indications for neoadjuvant treatment based on risk factors for poor prognosis before and after neoadjuvant chemotherapy alone in patients with locally advanced rectal cancer.
     Eur J Surg Oncol. 2021;47:1005-1011.
     PubMed     Abstract available
     
     
     
129. STERPETTI AV, Marzo LD, Sapienza P
     Risk factors for adenocarcinoma in the surgically transposed colon not exposed to the fecal stream. Etiological considerations extrapolated to sporadic colon carcinoma in the general population.
     Eur J Surg Oncol. 2021;47:931-934.
     PubMed     Abstract available
     
     
     
130. GAO TM, Bai DS, Qian JJ, Zhang C, et al
     Real-world clinical significance of nonbiological factors with staging, prognosis and clinical management in rectal cancer.
     Eur J Surg Oncol. 2021;47:990-998.
     PubMed     Abstract available
     
     
     April 2021
131. GILLIS C, Fenton TR, Gramlich L, Sajobi TT, et al
     Older frail prehabilitated patients who cannot attain a 400 m 6-min walking distance before colorectal surgery suffer more postoperative complications.
     Eur J Surg Oncol. 2021;47:874-881.
     PubMed     Abstract available
     
     
     
132. SCHULLIAN P, Johnston EW, Putzer D, Laimer G, et al
     Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
     Eur J Surg Oncol. 2021;47:866-873.
     PubMed     Abstract available
     
     
     
133. CONCI S, Ruzzenente A, Pedrazzani C, Isa G, et al
     Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes.
     Eur J Surg Oncol. 2021;47:842-849.
     PubMed     Abstract available
     
     
     
134. ASSI H, Persson A, Palmquist I, Oberg M, et al
     Sexual and functional long-term outcomes following advanced pelvic cancer and reconstruction using vertical rectus abdominis myocutaneous and gluteal myocutaneous flap.
     Eur J Surg Oncol. 2021;47:858-865.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: